Session II: Managing the human mycoses: An update
Moderators: Kieren A. Marr, MD and Jan E. Patterson, MD

Managing hematogenous candidiasis: Experience from the trenches
Carlos I. Bustamante, MD, FACP

Nosocomial fungal infections: Emerging pathogens and emerging sources
Maria Cecilia Dignani, MD

Zygomycosis: Changing epidemiology and practical guidelines for management
Luis Ostrosky-Zeichner, MD, FACP

Aspergillosis: Insights in classification, outcome definition, and recent management, or how do we know if the treatment really works?
Eric J. Bow, MD, MSc, D Bact, FRCPC

How I treat the endemic mycoses
Robert W. Bradsher, MD

Keynote Lecture: Discovery and development of antimicrobial agents: Meeting the challenges of generic agents, reduced reimbursements, parallel importation, regulatory guidelines, protein binding, efflux pumps, and points between
John H. Rex, MD
Introduction by Elias J. Anaissie, MD